206 related articles for article (PubMed ID: 25772440)
41. Cortically evoked potentials in the human subthalamic nucleus.
Zwartjes DG; Janssen ML; Heida T; Van Kranen-Mastenbroek V; Bour LJ; Temel Y; Visser-Vandewalle V; Veltink PH
Neurosci Lett; 2013 Feb; 539():27-31. PubMed ID: 23384566
[TBL] [Abstract][Full Text] [Related]
42. Cognitive activities in the subthalamic nucleus. Invasive studies.
Rektor I; Baláz M; Bocková M
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S83-6. PubMed ID: 20083016
[TBL] [Abstract][Full Text] [Related]
43. Movement-related coupling of human subthalamic nucleus spikes to cortical gamma.
Fischer P; Lipski WJ; Neumann WJ; Turner RS; Fries P; Brown P; Richardson RM
Elife; 2020 Mar; 9():. PubMed ID: 32159515
[TBL] [Abstract][Full Text] [Related]
44. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
45. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings.
von Wrangel C; Schwabe K; John N; Krauss JK; Alam M
Behav Brain Res; 2015 Feb; 279():52-61. PubMed ID: 25446762
[TBL] [Abstract][Full Text] [Related]
46. Axonal ER Ca
Mackay JP; Smith-Dijak AI; Koch ET; Zhang P; Fung E; Nassrallah WB; Buren C; Schmidt M; Hayden MR; Raymond LA
J Neurosci; 2023 May; 43(20):3743-3763. PubMed ID: 36944490
[TBL] [Abstract][Full Text] [Related]
47. Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.
Cepeda C; Oikonomou KD; Cummings D; Barry J; Yazon VW; Chen DT; Asai J; Williams CK; Vinters HV
J Neurosci Res; 2019 Dec; 97(12):1624-1635. PubMed ID: 31353533
[TBL] [Abstract][Full Text] [Related]
48. The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease.
Kuriakose R; Saha U; Castillo G; Udupa K; Ni Z; Gunraj C; Mazzella F; Hamani C; Lang AE; Moro E; Lozano AM; Hodaie M; Chen R
Cereb Cortex; 2010 Aug; 20(8):1926-36. PubMed ID: 20019146
[TBL] [Abstract][Full Text] [Related]
49. Preservation of the hyperdirect pathway of basal ganglia in a rodent brain slice.
Bosch C; Mailly P; Degos B; Deniau JM; Venance L
Neuroscience; 2012 Jul; 215():31-41. PubMed ID: 22537846
[TBL] [Abstract][Full Text] [Related]
50. Rhythmic bursting in the cortico-subthalamo-pallidal network during spontaneous genetically determined spike and wave discharges.
Paz JT; Deniau JM; Charpier S
J Neurosci; 2005 Feb; 25(8):2092-101. PubMed ID: 15728849
[TBL] [Abstract][Full Text] [Related]
51. M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus.
Conde-Berriozabal S; García-Gilabert L; García-García E; Sitjà-Roqueta L; López-Gil X; Muñoz-Moreno E; Boutagouga Boudjadja M; Soria G; Rodríguez MJ; Alberch J; Masana M
J Neurosci; 2023 May; 43(18):3379-3390. PubMed ID: 37001992
[TBL] [Abstract][Full Text] [Related]
52. Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease.
Fernández-García S; Orlandi JG; García-Díaz Barriga GA; Rodríguez MJ; Masana M; Soriano J; Alberch J
BMC Biol; 2020 May; 18(1):58. PubMed ID: 32466798
[TBL] [Abstract][Full Text] [Related]
53. Mouse subthalamic nucleus neurons with local axon collaterals.
Gouty-Colomer LA; Michel FJ; Baude A; Lopez-Pauchet C; Dufour A; Cossart R; Hammond C
J Comp Neurol; 2018 Feb; 526(2):275-284. PubMed ID: 28971478
[TBL] [Abstract][Full Text] [Related]
54. Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models.
Beaumont V; Zhong S; Lin H; Xu W; Bradaia A; Steidl E; Gleyzes M; Wadel K; Buisson B; Padovan-Neto FE; Chakroborty S; Ward KM; Harms JF; Beltran J; Kwan M; Ghavami A; Häggkvist J; Tóth M; Halldin C; Varrone A; Schaab C; Dybowski JN; Elschenbroich S; Lehtimäki K; Heikkinen T; Park L; Rosinski J; Mrzljak L; Lavery D; West AR; Schmidt CJ; Zaleska MM; Munoz-Sanjuan I
Neuron; 2016 Dec; 92(6):1220-1237. PubMed ID: 27916455
[TBL] [Abstract][Full Text] [Related]
55. The corticostriatal pathway in Huntington's disease.
Cepeda C; Wu N; André VM; Cummings DM; Levine MS
Prog Neurobiol; 2007 Apr; 81(5-6):253-71. PubMed ID: 17169479
[TBL] [Abstract][Full Text] [Related]
56. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Cummings DM; André VM; Uzgil BO; Gee SM; Fisher YE; Cepeda C; Levine MS
J Neurosci; 2009 Aug; 29(33):10371-86. PubMed ID: 19692612
[TBL] [Abstract][Full Text] [Related]
57. Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL/6J) Huntington's disease transgenic mice.
Brooks S; Higgs G; Janghra N; Jones L; Dunnett SB
Brain Res Bull; 2012 Jun; 88(2-3):113-20. PubMed ID: 20460143
[TBL] [Abstract][Full Text] [Related]
58. Subthalamic Activity for Motor Execution and Cancelation in Monkeys.
Polyakova Z; Hatanaka N; Chiken S; Nambu A
J Neurosci; 2024 Mar; 44(12):. PubMed ID: 38290848
[TBL] [Abstract][Full Text] [Related]
59. Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Joshi PR; Wu NP; André VM; Cummings DM; Cepeda C; Joyce JA; Carroll JB; Leavitt BR; Hayden MR; Levine MS; Bamford NS
J Neurosci; 2009 Feb; 29(8):2414-27. PubMed ID: 19244517
[TBL] [Abstract][Full Text] [Related]
60. Single-axon tracing of the corticosubthalamic hyperdirect pathway in primates.
Coudé D; Parent A; Parent M
Brain Struct Funct; 2018 Dec; 223(9):3959-3973. PubMed ID: 30109491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
